Скачать или смотреть Prostate Cancer Screening in BRCA1/2 Mutation Carriers | Insights from Hein V. Stroomberg

In this interview, Dr. Hein V. Stroomberg discusses his recent publication “Prostate-specific antigen screening at low thresholds of men with pathogenic BRCA1/2 variants.”
The study explores how lowering PSA thresholds could improve early detection of prostate cancer in men carrying BRCA1 or BRCA2 mutations, who are at higher genetic risk for aggressive disease.

Key discussion points include:

The rationale for adapting prostate cancer screening protocols in genetically predisposed men

Potential benefits and drawbacks of early PSA testing in BRCA1/2 carriers

Future perspectives on precision screening and personalized risk assessment

🧠 This video is part of our Prostate Cancer Insights Series, highlighting cutting-edge research from leading urologists and oncologists worldwide.

📖 Reference:
Stroomberg HV, Brasso K, Blak AA, Byrjalsen A, Hansen TvO, Røder A. Prostate-specific antigen screening at low thresholds of men with pathogenic BRCA1/2 variants.

⚠️ Disclaimer:
This content is intended for educational and informational purposes only. It does not constitute medical advice. Always consult your healthcare provider for clinical decisions.